Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

NEŞE ÜNVER

Doçent

Hacettepe Üniversitesi Kanser Enstitüsü Temel Onkoloji Anabilim Dalı

Research topics OpenAlex
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Temel İmmünoloji
Articles 20 YÖKSİS 20 · OpenAlex 0 Total citations 1,089 h-index 12 · OpenAlex Q1 articles 14 Scopus · WoS Q1 10 Best field rank #13,264 / 39,749 Main field · top 33.4% Co-authors 94 1 Turkish institutions

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 19 + YÖKSİS · co-author record: 5
h-index 12 Percentile in Türkiye: 87 #574 of 2,368 at their university by h-index
i10-index
13
Total citations
1,089
Top 5.4% in Türkiye
Per article
45.4
FWCI
2.56
1.00 = world average
World top 1%
2
World top 10%
7

Most cited articles

  1. IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets. 2018 world top 10% 243 citations
  2. IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer. 2016 world top 10% 225 citations
  3. Early exhumation of high pressure rocks in extrusion wedges Cycladic blueschist unit in the eastern Aegean Greece and Turkey 2007 world top 10% 157 citations
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 5 articles (186 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
94
With an akaturk profile
5
Turkish institutions
1
Co-authored works
%65

Academic co-authors 5

  1. GÜNEŞ ESENDAĞLI Profesör · Hacettepe Üniversitesi same university 5
  2. HANDE CANPINAR Doçent · Hacettepe Üniversitesi same university 2
  3. ARZU TOPELİ İSKİT Profesör · Hacettepe Üniversitesi same university 1
  4. ECE TAVUKÇUOĞLU DEMİR Doktor Öğretim Üyesi · Hacettepe Üniversitesi same university 1
  5. YASİN KAYMAZ Doktor Öğretim Üyesi · Ege Üniversitesi 1

National collaboration 1 institutions

Within own university6 joint works · Hacettepe Üniversitesi

  1. Ege Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 89

Edwin J. Ostrin 4Samir Hanash 4Amber Cumpian 3Dicle Guc 3Ignacio I. Wistuba 3Mauricio S. Caetano 3Seyed Javad Moghaddam 3Carmen Behrens 2Güldal Yılmaz 2Hiroyuki Katayama 2Hong Wang 2Humam Kadara 2Seon Hee Chang 2Soudabeh Daliri 2Adi F. GazdarAndrei M. AlekseevAyse YuzbasiogluAysen KaradumanAyumu TaguchiBahar Zehra WEBERBarbara MinoBelinda J. HernandezBerenice A. GutierrezBurcin HalacliCarlos Gil FerreiraCesar E. OchoaCinthya SternbergClemente Aguilar-BonavidesCynthia De la Garza RamosDelphine DaydeDilsher DhillonECE TAVUKÇUOĞLUERMİŞ Diğdem YÖYENEbru Ortac ErsoyEdwin R. ParraElif Duymaz YılmazEva SzaboFatma GumrukFigen GurakanFlorencia McAllister

Show all (89)

Francesco StingoGargy ParhyHaruki MoriHua YuHuiyuan ZhangIchidai TanakaJaime Rodriguez-CanalesJennifer B. DennisonJichao ChenJohannes F. FahrmannJulian Phillip CasabarJunya FujimotoKim-Anh DoKirubel ZelekeKohei YokoiKoji KawaguchiLei GongLuisa M. SolisMasahiro NakatochiMei Chee TaiMuge CeliktasNasim KhosraviOliver DelgadoOnurcan SezginerOscar NoblePhilip L. LorenziRekha JainRoza NurievaSILA ULUTÜRKSatyendra C. TripathiScott E. EvansSeiichi KatoSerap EmreSerpil OcalSevil Oskay HalacliSibel Ersoy EvansStephanie S. WatowichTaisuke KajinoTakayuki FukuiTetsunari HaseToyofumi F. Chen-YoshikawaVeera BaladandayuthapaniWaki HosodaXiming TangYahya BuyukasikYasushi YatabeYi YangYoshiko MurakamiYoshinori Hasegawa

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Indexes and citation percentiles

?
TR Index 3 articles
OpenAlex citation percentile
Top 1%2
Top 10%6
Avg · n 19 %71.8
Other counts

Scopus (SJR)

  • YÖKSİS rows 18

WoS (JCR)

  • YÖKSİS rows 18

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

20articles

Journals with publications

17 journals

Narrow down

Scopus (SJR)
Q114 Q24 Q30 Q40
WoS (JCR)
Q110 Q23 Q35 Q40
TR Index
3articles

Article list

  1. 2025 The impact of aspirin on PD-L1 expression and alteration of M2 polarization in non-small cell lung cancer. INFLAMMATION RESEARCH DOI 10.1007/s00011-025-02091-8 YÖKSİS SJR Q1 JCR Q1 OpenAlex 57.0%
  2. 2025 Aspirin's effect on macrophages beyond its chemopreventive role in inflammation and cancer. Inflammopharmacology DOI 10.1007/s10787-025-01945-1 YÖKSİS SJR Q1 JCR Q1 OpenAlex 71.4%
  3. 2024 Dissection of pro-tumoral macrophage subtypes and immunosuppressive cells participating in M2 polarization Inflammation Research DOI 10.1007/s00011-024-01907-3 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.6%
  4. 2023 Sophisticated genetically engineered macrophages, CAR-Macs, in hitting the bull's eye for solid cancer immunotherapy approaches Clinical and Experimental Medicine DOI 10.1007/s10238-023-01106-0 YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.8%
  5. 2022 SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas. Journal of the National Cancer Institute DOI 10.1093/jnci/djab183 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.0%
  6. 2022 Tailored modulation of stemness and drug resistance marker characteristics in K-Ras mutant lung cancer cells via PD-L1 gene suppression. Life sciences DOI 10.1016/j.lfs.2022.121171 YÖKSİS SJR Q1 JCR Q1 OpenAlex 42.9%
  7. 2021 Revisiting CCL-type chemokines in breast cancer and its milieu: prominent targetable chemokines, CCL8 and CCL21 Bioscience Reports DOI 10.1042/BSR20210033 YÖKSİS SJR Q2 JCR Q3 OpenAlex 49.0%
  8. 2021 Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools Medical Oncology DOI 10.1007/s12032-021-01517-7 YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.2%
  9. 2021 Cancer Stemness as a Target for Immunotherapy is Shaped by Proinflammatory Stress Current Stem Cell Research & Therapy DOI 10.2174/1574888X15666200309145901 YÖKSİS SJR Q2 JCR Q3 OpenAlex 51.3%
  10. 2021 In-Silico Analysis of The Correlation Between PD-L1 and Pro-Inflammatory Type Interleukins and The Distribution of Their Potential Primary Sources in KRAS-Mutated Non-Small Cell Lung Carcinoma Acta Medica DOI 10.32552/2021.ActaMedica.559 YÖKSİS TR Index OpenAlex 13.0%
  11. 2020 Transcriptional splice variants of CD40 and its prognostic value in breast cancer TURKISH JOURNAL OF BIOLOGY DOI http://online.journals.tubitak.gov.tr/openDoiPdf.htm?mKodu=biy-1912-21 YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 62.0%
  12. 2019 Macrophage chemoattractants secreted by cancer cells: Sculptors of the tumor microenvironment and another crucial piece of the cancer secretome as a therapeutic target. Cytokine Growth Factor Rev. YÖKSİS SJR Q1 JCR Q1
  13. 2018 IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets. CYTOKINE GROWTH FACTOR REVIEWS DOI 10.1016/j.cytogfr.2018.04.004 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 92.5%
  14. 2018 IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Sternness Properties. CANCER IMMUNOLOGY RESEARCH DOI 10.1158/2326-6066.CIR-17-0655 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 93.1%
  15. 2018 Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol. INTERNATIONAL JOURNAL OF CANCER DOI 10.1002/ijc.31152 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 90.5%
  16. 2018 Regulatory Role of Chemerin in Lung Tumorigenesis and Cancer-associated Inflammation Acta Medica DOI https://actamedica.org/index.php/actamedica/article/view/278 YÖKSİS TR Index OpenAlex 50.8%
  17. 2016 IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer. CANCER RESEARCH DOI 10.1158/0008-5472.CAN-15-2840 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 98.6%
  18. 2016 Investigation of hemophagocytic lymphohistiocytosis in severe sepsis patients. JOURNAL OF CRITICAL CARE DOI 10.1016/j.jcrc.2016.04.034 YÖKSİS SJR Q1 JCR Q2 OpenAlex 89.0%
  19. 2015 CXCL7-induced macrophage infiltration in lung tumor is independent of CXCR2 expression CXCL7-induced macrophage chemotaxis in LLC tumors CYTOKINE DOI 10.1016/j.cyto.2015.07.018 YÖKSİS SJR Q1 JCR Q2 OpenAlex 76.4%
  20. 2010 Molecular analysis of Chanarin-Dorfman syndrome (CDS) patients: Identification of novel mutations in the ABHD5 gene EUROPEAN JOURNAL OF MEDICAL GENETICS DOI 10.1016/j.ejmg.2010.03.002 YÖKSİS SJR Q1 JCR Q3 OpenAlex 83.9%

← Back to academicians